Medit · 2 months ago
Senior Manager, Regulatory & Quality Affairs
Medit is a global leader in 3D dental imaging and digital dentistry, and they are seeking a senior-level RA/QA expert to own and lead their regional compliance strategy. This role involves managing regulatory and quality operations for both medical device hardware and software as a medical device across the U.S., Canada, and LATAM, including FDA submissions and ISO compliance.
3D TechnologyDentalHealth CareMedicalMedical Device
Responsibilities
Lead and manage Class II regulatory submissions including FDA 510(k), Health Canada, ANVISA, and LATAM filings for both hardware and software
Serve as U.S. and LATAM regulatory liaison with global HQ and local authorities
Monitor evolving regulations and proactively adjust strategy across jurisdictions
Ensure ongoing compliance with ISO 13485, MDSAP, and QSR requirements
Own and maintain quality assurance systems, CAPAs, SOPs, and change control
Support audits and inspections from FDA, Health Canada, and other regulators
Work closely with R&D, product, legal, and support teams to ensure regulatory alignment
Guide internal teams on regulatory best practices and QA processes
Represent Medit in external conversations with regulatory bodies and partners
Qualification
Required
7–10+ years of experience in Regulatory Affairs and Quality Assurance, ideally with both medical devices and digital health products
Demonstrated success leading FDA Class II 510(k) submissions, especially for SaMD
Strong knowledge of ISO 13485, MDSAP, QSR, and related standards
Experience operating independently in cross-border environments (U.S., Canada, LATAM)
Proven ability to make decisions and drive compliance without heavy oversight
Excellent project management and documentation skills
Bachelor's degree required
English fluency required
Preferred
Advanced degree or RAC certification a plus
Spanish or Portuguese is a plus
Company
Medit
MEDIT provides 3D measurement solution services for dental clinics and labs.
Funding
Current Stage
Growth StageTotal Funding
unknown2022-12-29Acquired
2019-12-01Series Unknown
2019-04-01Series Unknown
Recent News
prnasia.com
2025-12-15
Morningstar.com
2025-12-09
Morningstar.com
2025-12-01
Company data provided by crunchbase